491 related articles for article (PubMed ID: 26173170)
1. Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study.
Liao JN; Chao TF; Liu CJ; Wang KL; Chen SJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Tsao HM; Chen TJ; Lip GY; Chen SA
Int J Cardiol; 2015 Nov; 199():25-30. PubMed ID: 26173170
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
[TBL] [Abstract][Full Text] [Related]
3. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study.
Chao TF; Huang YC; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Hsieh MH; Lip GY; Chen SA
Heart Rhythm; 2014 Nov; 11(11):1941-7. PubMed ID: 25101483
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
[TBL] [Abstract][Full Text] [Related]
5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CHA
Hu WS; Lin CL
Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919
[TBL] [Abstract][Full Text] [Related]
7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
8. CHA
Hu WS; Lin CL
Int J Cardiol; 2017 May; 235():56-60. PubMed ID: 28262350
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.
Saliba W; Gronich N; Barnett-Griness O; Rennert G
Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854
[TBL] [Abstract][Full Text] [Related]
10. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
11. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
12. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
13. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
14. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study.
Lai HC; Chien WC; Chung CH; Lee WL; Wu TJ; Wang KY; Liu CN; Liu TJ
Eur J Intern Med; 2015 Dec; 26(10):798-806. PubMed ID: 26493861
[TBL] [Abstract][Full Text] [Related]
16. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
17. The CHADS
Barkas F; Elisaf M; Korantzopoulos P; Tsiara S; Liberopoulos E
Int J Cardiol; 2017 Aug; 241():194-199. PubMed ID: 28442233
[TBL] [Abstract][Full Text] [Related]
18. CHA
Graves KG; May HT; Jacobs V; Knowlton KU; Muhlestein JB; Lappe DL; Anderson JL; Horne BD; Bunch TJ
Heart Rhythm; 2019 Jan; 16(1):3-9. PubMed ID: 30611392
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
Lai HC; Chien WC; Chung CH; Lee WL; Wang KY; Wu TJ; Liu CN; Liu TJ
Int J Cardiol; 2015 Oct; 197():133-9. PubMed ID: 26126057
[TBL] [Abstract][Full Text] [Related]
20. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
